Eli Lilly launches weight-loss drug Mounjaro in India after drug regulator approval
By Thomson ReutersMar 20, 2025 | 3:43 AM
(Reuters) -Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from country’s drug regulator, it said on Thursday.
(Reporting by Rishika Sadam and Manvi Pant; Editing by Janane Venkatraman)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at (517) 279-1590.
Comments